[SCHEDULE 13G/A] Omada Health, Inc. Amended Passive Investment Disclosure
FMR LLC reports 3.29M shares (5.6%) in Omada
Omada Health Inc. filing an amendment to Schedule 13G/A discloses that FMR LLC beneficially owned 3,288,380 shares of Omada common stock, representing 5.6% of the class as of 03/31/2026.
Omada Health Inc. filing an amendment to Schedule 13G/A discloses that FMR LLC beneficially owned 3,288,380 shares of Omada common stock, representing 5.6% of the class as of 03/31/2026. The filing lists sole dispositive power for 3,288,380 shares and references an Exhibit 99 13d-1(k) agreement and a power of attorney.
The filing is an ownership disclosure by an institutional investor under Schedule 13G/A and does not state any transaction activity or changes in holdings beyond the reported position.
Positive
None.
Negative
None.
Insights
FMR LLC holds a passive >5% stake reported via Schedule 13G/A.
The filing shows 3,288,380 shares (5.6%) beneficially owned as of 03/31/2026, with sole dispositive power listed. This is a standard disclosure by an investment manager when passive ownership thresholds are exceeded.
Impact depends on future filings; subsequent amendments or a Schedule 13D would be required if ownership becomes active. Referenced Exhibit 99 and the power of attorney document the filing mechanics.
Key Figures
Shares beneficially owned:3,288,380 sharesPercent of class:5.6%CUSIP:68170A108+3 more
6 metrics
Shares beneficially owned3,288,380 sharesReported as of 03/31/2026
Percent of class5.6%Reported percent of outstanding common stock
CUSIP68170A108Omada Health common stock CUSIP
Sole voting power (cover)3,286,726 sharesSole voting power listed on the cover
Sole dispositive power3,288,380 sharesSole dispositive power reported
Schedule type13G/A Amendment No. 2Amendment to passive investor disclosure
"Amendment No. 2 to Schedule 13G/A discloses beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
Beneficially ownedfinancial
"Amount beneficially owned: 3288380.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Dispositive powerregulatory
"Sole power to dispose or to direct the disposition of: 3288380.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
13d-1(k)(1) agreementregulatory
"Please see Exhibit 99 for 13d-1(k)(1) agreement"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does FMR LLC report in OMDA?
FMR LLC reports beneficial ownership of 3,288,380 shares, equal to 5.6% of Omada Health common stock as of 03/31/2026. The filing lists sole dispositive power over those shares.
Does the Schedule 13G/A show any share purchases or sales?
No; this amendment reports an ownership position and does not disclose any specific purchases or sales. It records beneficial ownership and voting/dispositive powers rather than transaction details.
What is the significance of Exhibit 99 and the power of attorney cited?
Exhibit 99 references a 13d-1(k)(1) agreement and the power of attorney documents authority for signatures. They document filing mechanics and legal authority but do not alter the reported share count.
Who signed the Schedule 13G/A for FMR LLC?
The filing is signed by Richard Bourgelas as a duly authorized signatory under a power of attorney effective April 13, 2026, submitted on behalf of FMR LLC and Abigail P. Johnson.
What voting or dispositive power does FMR LLC have over the shares?
The filing lists sole dispositive power of 3,288,380 shares and indicates sole voting power reported on the cover as 3,286,726 shares; shared powers are 0.00 according to the cover data.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
OMADA HEALTH INC
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
68170A108
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
FMR LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
3,286,726.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,288,380.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,288,380.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
68170A108
1
Names of Reporting Persons
Abigail P. Johnson
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
3,288,380.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,288,380.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
OMADA HEALTH INC
(b)
Address of issuer's principal executive offices:
611 GATEWAY BLVD,UITE 120,SOUTH SAN FRANCISCO,CA,US,94080
Item 2.
(a)
Name of person filing:
FMR LLC
(b)
Address or principal business office or, if none, residence:
245 Summer Street, Boston, Massachusetts 02210
(c)
Citizenship:
Not applicable
(d)
Title of class of securities:
COMMON STOCK
(e)
CUSIP No.:
68170A108
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
3288380.00
(b)
Percent of class:
5.6 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Please see the responses to Items 5 and 6 on the cover page.
(ii) Shared power to vote or to direct the vote:
0.00
(iii) Sole power to dispose or to direct the disposition of:
3288380.00
(iv) Shared power to dispose or to direct the disposition of:
0.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of OMADA HEALTH INC. No one other person's interest in the COMMON STOCK of OMADA HEALTH INC is more than five percent of the total outstanding COMMON STOCK.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See attached Exhibit 99.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
FMR LLC
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:
05/05/2026
Abigail P. Johnson
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:
05/05/2026
Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
